Unusual Epigenetic Modifier Drives Some Cancers While Inhibiting Others
In a remarkable breakthrough, researchers at Rockefeller University have unveiled novel insights into the epigenetic modifier MLL4, a protein complex ...
In a remarkable breakthrough, researchers at Rockefeller University have unveiled novel insights into the epigenetic modifier MLL4, a protein complex ...
In a groundbreaking study poised to reshape the therapeutic landscape of aggressive breast cancers, researchers have uncovered a novel metabolic ...
In the relentless battle against lung cancer, tumor-associated macrophages (TAMs) have emerged as pivotal players within the tumor microenvironment, orchestrating ...
In a groundbreaking advancement that could redefine therapeutic strategies for leukemia, researchers have unveiled the promising role of daidzein, a ...
In a groundbreaking advancement in cancer research, scientists have unveiled the pivotal role of KMT2A silencing in orchestrating apoptosis and ...
In a groundbreaking new study published in BMC Cancer, researchers have unveiled compelling evidence that simultaneous inhibition of EZH2 and ...
In a groundbreaking study published in BMC Cancer, researchers uncover pivotal insights into the role of UHRF1 in the progression ...
Prostate cancer remains one of the most significant health challenges faced by men worldwide, characterized by its dependence on complex ...
In the relentless pursuit of groundbreaking cancer therapies, a novel twist in the complex battle against tumor immune evasion has ...
Peptidyl-arginine deiminase 2 (PAD2) has emerged as a pivotal enzyme driving the progression of pancreatic ductal adenocarcinoma (PDAC), one of ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine